During lytic infection, the virion host shutoff (vhs) protein of alphaherpesviruses causes the degradation of mRNAs nonspecifically. In this work, we cloned the vhs gene (UL41 open reading frame) of pseudorabies virus (PRV; TNL strain) by PCR, and its nucleotide sequences were determined. The PCR product of vhs gene was subcloned into the prokaryotic pET32b expression vector, and production of the recombinant vhs protein was examined by SDS-PAGE. Result of Western blotting demonstrated that our recombinant vhs protein reacted with antiserum against a synthetic peptide of 17 amino acids of the vhs protein. After purification with nickel-chelate affinity chromatography, the purified recombinant vhs protein exhibited in vitro ribonuclease activity as expected. We further cloned the vhs gene into eukaryotic expression vectors and investigated the intracellular function of vhs protein by DNA transfection. By transient trasfection and CAT assay, we found the CAT activity was reduced in the presence of vhs, indicating that degradation of mRNA of the CAT gene was caused by the vhs. Furthermore, our results showed that the plaque formation of pseudorabies virus was blocked by exogenous vhs. Taken together, we have cloned the vhs gene of pseudorabies virus (TNL strain) and conducted functional analysis of the recombinant vhs protein in vitro as well as in vivo.
Introduction
Pseudorabies virus (PRV) is a member of Alphaherpesvirinae in the family Herpesviridae, causing Aujeszky's disease of pigs (Mettenleiter, 1994) . Human herpes simplex virus 1 (HSV-1) is the prototype of this family and has been extensively studied (Roizman and Knippe, 2001 ). HSV-1 carries a structural protein, the virion host shutoff (vhs) protein that causes the inhibition of host protein synthesis by degradation of cellular mRNAs after infection (Fenwick and Clark, 1982) . The vhs protein is encoded by the UL41 gene and is a component in the tegument of a virion. Upon viruses entering into the cell, this tegument protein exerts its deleterious effects to the host immediately and does not require virus protein synthesis (Becker et al., 1993; Karr and Read, 1999; Oroskar and Read, 1989; Read, 1997; Read et al., 1993; Schek and Bachenheimer, 1985; Smibert et al., 1992) . Following the onset of viral gene expression, vhs also causes the decay of viral mRNAs, implying that vhs plays a role in the regulation of differential expression of viral genes Kwong and Frenkel, 1987; Oroskar and Read, 1989; Read, 1997) . In late time of lytic infection, the vhs protein is produced again, sequestered and inactive, and eventually packaged into the progeny virions Frenkel, 1987, 1989; Lam et al., 1996; Read et al., 1993; Smibert et al., 1994) .
The precise mechanism of accelerated mRNA turnover and inhibition of protein synthesis remains unclear. The requirement of mammalian factor(s) for efficient activity of vhs protein has been suggested (Lu et al., 2001 ). In addition, it was found that the vhs is a viral mRNA degradation factor, targeted to mRNAs and to the translation initiation stage, through an interaction with initiation factor eIF4H (Feng et al., 2001) .
The UL41 gene is conserved in alphaherpesviruses, including HSV-1, HSV-2, PRV, varicella-zoster virus (VZV), bovine herpesvirus 1 (BHV-1), and equine herpesvirus 1 (EHV-1) (Davison and Scott, 1986; Everett and Fenwick, 1990; Feng et al., 1996; Hinkley et al., 2000; Telford et al., 1992 ). An unusual feature of the vhs of alphaherpesviruses is that it lacks primary sequence similarity to known RNases except a weak similarity to the FEN-1family of nucleases (Everly et al., 2002; Lu et al., 2001; Stevens, 1998) . Although the sequences of the vhs gene in PRV genome have been documented (Berthomme et al., 1993) , the biochemical properties of the PRV vhs gene product have not been studied yet. In this paper, we reported the cloning of the vhs gene of PRV and functional studies on the recombinant vhs protein.
Results and discussion
The vhs gene is in the UL41 region of PRV genome (Berthomme et al., 1993) . Using appropriate primers (vhs-R and vhs-F) and applying PCR, we have successfully cloned the vhs gene. The DNA fragment (approximately 1.2 kb) of PCR was further subcloned into the pCRII vector ( Fig. 1 ) and the resulting plasmid was designated as pCRII-vhs. Automated DNA sequenceing was carried out to confirm the nucleotide identity of our PCR product. Our sequence data of vhs gene of TNL strain exhibited a 97.8% similarity to that of Ka strain; the deduced amino acid sequence similarity was 98%.
To express the recombinant vhs protein, the pCRII-vhs was cut with HindIII and EcoRV to generate the insert, which was further cloned into the pET32b prokaryotic expressing vector. The expressing plasmid was named as pET32b-vhs (Fig. 1) .
The pET32b-vhs was introduced into E. coli BL21 (DE3) pLysS and IPTG was used for the induction of the vhs protein.
As shown in Fig. 2 , the results of SDS-PAGE demonstrated that significant amounts of the recombinant vhs protein (59 kDa) were produced. The partial identity of this recombinant protein was examined by N-terminal amino acid sequencing to ensure the reading frame is correct (data not shown).
Although the biochemical and biological functions of the vhs gene of HSV were investigated extensively, it appears that the high level of expression and purification of a recombinant vhs protein in prokaryotic system was not reported yet (Elgadi et al., 1999; Everly et al., 2002; Krikorian and Read, 1991; Leib, 1995, 1996) . In the following, we performed several in vitro and in vivo experiments to examine the properties and functions of the recombinant vhs protein of PRV.
For immunological study, the recombinant vhs protein was purified by affinity chromatography, analyzed by SDS-PAGE, and identified by Western blotting. We found that it could be recognized either by rabbit polyclonal anti-PRV antibody or by rabbit polyclonal antibody against a synthetic 17-amino-acid peptide of vhs (Fig. 3) . The native vhs protein of the PRV virion could also react with the polyclonal antibody against a synthetic peptide of vhs (Fig. 3B ). Our Western blot data revealed that this 17-amino-acid peptide (between box II and box III of the vhs polypeptide) is an epitope shared by the recombinant vhs and native vhs protein in the virion. There are four conserved regions (boxes I, II, III, and IV) in the vhs genes of herpesviruses (Berthomme et al., 1993) .
To examine the in vitro RNase activity of recombinant vhs protein, RNA markers were incubated with purified vhs protein and analyzed with agarose gel electrophoresis. Results showed that the purified vhs protein degraded RNA samples rapidly (Fig. 4A, lanes 4 -6) . By contrast, the negative control experiment, in which the reaction solution was eluted from empty vector pET32b, demonstrated that no endogenous ribonuclease activity was observed (Fig. 4A, lanes 1 -3) , indicating that the RNA was degraded by the recombinant vhs protein. We also constructed a vhs mutant with four-amino-acid (SDRG) deletion in the conserved box II region and we found this mutant demonstrated partial nuclease activity (Fig. 4B ). This observation was consistent with the in vitro ribonucleolytic activity of HSV-1 vhs protein, which was extracted from virions or was in vitro-translated (Zelus et al., 1996) . A recent report also provided the evidence that the vhs protein of HSV-1 is an RNase, either alone or forming a complex with translational factor eIF4H (Everly et al., 2002) . Moreover, we tested the DNase activity of purified vhs protein, and we found no DNase activity was associated with the vhs protein preparation (data not shown).
To assess the intracellular function of vhs gene, we cloned the vhs gene into eukaryotic expressing vectors. The expression of the vhs gene was under the control of a cytomegalovirus (CMV) promoter (pcDNA3.1-vhs) or a gE promoter (pgEp-vhs) of PRV glycoprotein E, which was cloned in our laboratory (Chang et al., 2002) . Previous studies have shown that vhs of HSV can function in the absence of other viral gene products (Jones et al., 1995; Pak et al., 1995) . Using transient transfection and CAT assay, we observed that the CAT activity was blocked by cotransfection of plasmid containing vhs gene (Fig. 5) . It was reasonable to conclude that the reduced CAT activity resulted from the intracellular degradation of mRNA of CAT gene by vhs and that the vhs of PRV can also be functional in the absence of other viral products.
It was shown that the vhs protein of HSV inhibited the replication of human immunodeficiency virus (Hamouda et al., 1997) . Therefore, we explored the effect of the recombinant vhs on the plaque formation of PRV. Cells were transfected with pgEp-vhs or pgEp-EGFP (EGFP, enhanced green fluorescent protein gene; Clontech, BD Biosciences); both plasmids bear the promoter of PRV glycoprotein E gene to control vhs or EGFP gene, respectively (Chang et al., 2002) . Following 16 h of transfection, cells were infected with PRV; then plaque assay was conducted. We found that there was an approximately 70% reduction in plaque formation in the presence of vhs. In contrast, the result of a similar experiment using EGFP was essentially same as that of the control (Fig. 6 ). Our finding indicated that the vhs, through its nonspecific ribonucleolytic activity, caused global damage to the cell function and accordingly the following PRV infection was unable to finish normally.
Materials and methods

Virus and cells
The genomic DNA of pseudorabies virions (TNL strain) was isolated from PRV-infected Madin -Darby bovine kidney (MDBK) cells by sucrose gradient as described previously (Wong and Chen, 1998) . LM (tk À ) cells were maintained in Dulbecco's modified Eagle medium (DMEM; GIBCO BRL) supplemented with 10% fetal bovine serum (Hyclone), penicillin (100 IU/ml), and streptomycin (100 Ag/ml).
Polymerase chain reaction (PCR) and sequencing
Genomic DNA of PRV was used as templates in PCR. PCR was carried out in a 50-Al mixture containing 1 Al (0.1 Ag) viral DNA, 2 AM of the primers vhs-F (5V-TGTGCGAGCGGAGACATGGGCT-3V) and vhs-R (5V-AGAGGGCGAGCATCACAC-3V), 1.25 u of Taq DNA polymerase (TaKaRa), 50 mM KCl, 10 mM Tris (pH 8.3), 1.5 mM MgCl 2 , 0.25 mM of each dNTP, and 5 Al DMSO. The PCR program was 35 cycles consisting of 1 min at 94 jC for denaturation, 30 s at 55 jC for annealing, and 1 min at 72 jC for extension. A DNA fragment of 1.2 kb was of the PCR product was examined by agarose gel electrophoresis, and the desired DNA fragments were eluted for the following experiment. The nucleotide identity of the PCR product was determined by automated DNA sequencer.
Plasmid construction
PCR products were cloned into the pCRII vector (Invitrogen), and the result plasmid was named pCRII-vhs. The pCRII-vhs was checked with restriction enzyme digestion and agarose gel electrophoresis. The DNA fragment of the vhs gene was cleaved out by EcoRV -HindIII and subcloned into the EcoRV -HindIII sites of pET32b vector (Novagen) and the resulting plasmid was named pET32b-vhs.
To construct plasmids for transfection experiments, the DNA fragment of the vhs gene was cleaved out from pCRIIvhs by EcoRV -BamHI and subcloned into the EcoRVBamHI sites of pcDNA3.1 eukaryotic expression vector (Invitrogen), and the resulting plasmid was named as pcDNA3.1-vhs.
Mutant construction
Genomic DNA of PRV was used as template in PCR. PCR was carried out in a 50-Al mixture containing 1 Al (0.1 Ag) viral DNA, 2 AM of the primers vhs-F (5V-TGTGCGAGCGGAGACATGGGCT-3V) and vhs-Rd-1(GCGGTCGTCGACGAAGATGGGGAAGTA-3V) or vhs-FdN (5V-GTCTCGGACCGCGATATCTTCGGGAAC-3V) and vhs-R (5V-AGAGGGCGAGCATCACAC-3V), 1.25 u of Taq DNA polymerase (TaKaRa), 50 mM KCl, 10 mM Tris (pH 8.3), 1.5 mM MgCl 2 , 0.25 mM of each dNTP, and 5 Al DMSO. The PCR program was 45 cycles consisting of 30 s at 94 jC for denaturation, 30 s at 55 jC for annealing, and 1 min at 72 jC for extension. The nucleotide identity of the PCR product was determined by automated DNA sequencer. PCR products were cloned into the pGEM-T-Easy vector (Promega), and the result plasmids were named pGEM-T-Zvhs-F/Rd-1 and pGEM-T-Z-vhs-Fd/R. The insert in pGEM-T-Z-vhs-F/Rd-1 was cleaved out by HincII and subcloned into the EcoRV site of pGEM-T-Z-vhs-Fd/R, and the resulting plasmid was named pGEM-T-Z-vhsm3, which was a vhs mutant with four-amino acid deletion. The DNA fragments of the wild-type vhs and mutated vhsm3 were cleaved out by PstI and subcloned into the PstI sites of pET44a expression vector (Novagen), respectively; and the resulting plasmids were named pET44a-vhs and pET44a-vhsm3.
Expression, purification, and identification of vhs protein
The pET32b-vhs was introduced into E. coli BL21 (DE3) pLysS and the expression of vhs was induced with IPTG (isopropyl-h-D-thiogalactopyranoside) treatment. The bacterial lysate was separated by SDS -10% polyacrylamide gel electrophoresis (SDS-PAGE), and the gel was stained with Coomassie blue. For purification of 6xHis-tagged protein under native condition, we used nickel-chelate affinity chromatography to purify the recombinant vhs as well as the control Trx Á Tag protein (QIAGEN). For immunoblotting, the gel was further transferred to a nitrocellulose membrane (NEN). The membrane was incubated in blocking buffer for 1 h at room temperature and then incubated for 1 h with rabbit antiserum (CashmereBiotech, Taipei) against a synthetic peptide (amino acid one-letter symbol: ADGDGAADAPPRPRWST) of vhs protein at 800-fold dilution. Unbound antiserum was removed by washing the membrane three times in PBST for 5 min. The second antibody was peroxidase-labeled anti-rabbit antibody (NEN) and was incubated for 1 h at room temperature. The final method for detection was the ECL detection system (Amersham Pharmacia Biotech).
N-terminal amino acid sequencing
Following SDS-PAGE, the gel was stained with Coomassie blue and the proteins were transferred to PVDF membrane (NEN Life Science). The desired band on the membrane was cut off for automated amino acid sequencing, which was carried out in the Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan.
RNase activity in vitro
The commercial RNA marker (1 mg/ml; Ambion) (1 Ag) and purified vhs protein (1 Ag) were co-incubated in the elution buffer (50 mM NaH 2 PO 4 (pH 8.0), 300 mM NaCl, 250 mM imidazole) at 37 jC for 20, 40, and 80 min, respectively. Then the reaction mixture was analyzed with 1% agarose RNA denaturing gel.
Transfections and CAT assay
Using the Poly-Fect transfection kit (QIAGEN), freshly cultured LM (tk À ) cells were transfected with plasmid DNA of pcDNA3.1-vhs, pgEp-vhs, pcDNA-3.1, or pCAT-Promoter (alone or in combination). After 48 h of transfection, cells were scraped and disrupted by freezing and thawing three times, and the CAT reaction was carried out with the method developed by Gorman et al. (1982) . Following the reaction, the non-acetylated (CAM) and acetylated (Ac-CAM) forms of ( 14 C)-labeled chloramphenicol were separated by silica thin layer chromatography (TLC), and the silica sheet was exposed to X-ray film for autoradiography.
Plaque assay
For plaque assay, confluent monolayers of LM (tk À ) cells were either mock or were transfected with pgEp-vhs or pgEp-EGFP. At the 16 h after transfection, cells were infected with PRV by the multiplicities of infection (MOI) of 0.1 PFU/cell. The inoculum was removed after additional 2 h and cells were then overlaid with medium containing 1% methylcellulose. After 48 h of infection, the plaque formation was visualized by staining with 0.5% crystal violet. 
